Showing 1 to 9 of 9 results
These data tables look at top drug classes in terms of public drug program spending and rate of use by jurisdiction, sex, age group and neighbourhood income.
These data tables provide international comparisons for pharmaceutical spending.
This document describes the methodology used to generate the related report.
This report looks at public drug program spending in 2017 in all provinces, Yukon and 1 federal program administered by the First Nations and Inuit Health Branch.
Take an in-depth look at prescribed drug spending in Canada and learn more about how different drug classes contribute to current trends in total public drug spending.
Family doctor preparedness (HTML)
The growing number of seniors living with dementia is leaving some primary care doctors feeling less well-prepared to manage dementia care in the community.
About 61% of seniors with dementia in Canada live at home — and they require support while staying there.
In long-term care, seniors with dementia are at higher risk of being physically restrained and given potentially inappropriate antipsychotic drugs than other seniors. However, policy changes and educational supports have helped spur a decrease in this trend over the past several years.
Young-onset dementia (HTML)
Canadians with young-onset dementia present unique care challenges Fewer Canadians are diagnosed with dementia before age 65 than as seniors — but their needs can be just as great. At the time of diagnosis, people with young-onset dementia may still be working, taking care of their children and parents, and meeting financial commitments. Learn more about how care is different for people with young-onset dementia.